286 related articles for article (PubMed ID: 20636025)
1. Lymphoma immunotherapy: vaccines, adoptive cell transfer and immunotransplant.
Brody J; Levy R
Immunotherapy; 2009 Sep; 1(5):809-24. PubMed ID: 20636025
[TBL] [Abstract][Full Text] [Related]
2. A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions.
Marofi F; Rahman HS; Achmad MH; Sergeevna KN; Suksatan W; Abdelbasset WK; Mikhailova MV; Shomali N; Yazdanifar M; Hassanzadeh A; Ahmadi M; Motavalli R; Pathak Y; Izadi S; Jarahian M
Front Immunol; 2021; 12():681984. PubMed ID: 34248965
[TBL] [Abstract][Full Text] [Related]
3. Checkpoint inhibition and cellular immunotherapy in lymphoma.
Lulla P; Heslop HE
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):390-396. PubMed ID: 27913506
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cell vaccines for cancer immunotherapy.
Timmerman JM; Levy R
Annu Rev Med; 1999; 50():507-29. PubMed ID: 10073291
[TBL] [Abstract][Full Text] [Related]
5. Active and passive immunotherapy for lymphoma: proving principles and improving results.
Brody J; Kohrt H; Marabelle A; Levy R
J Clin Oncol; 2011 May; 29(14):1864-75. PubMed ID: 21482977
[TBL] [Abstract][Full Text] [Related]
6. Vaccination strategies in the treatment of lymphomas.
Veelken H; Osterroth F
Oncology; 2002; 62(3):187-200. PubMed ID: 12065865
[TBL] [Abstract][Full Text] [Related]
7. An Update on Adoptive T-Cell Therapy and Neoantigen Vaccines.
Ott PA; Dotti G; Yee C; Goff SL
Am Soc Clin Oncol Educ Book; 2019 Jan; 39():e70-e78. PubMed ID: 31099621
[TBL] [Abstract][Full Text] [Related]
8. Emerging Role of CAR T Cells in Non-Hodgkin's Lymphoma.
Avanzi MP; Brentjens RJ
J Natl Compr Canc Netw; 2017 Nov; 15(11):1429-1437. PubMed ID: 29118234
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cell-based combined immunotherapy with autologous tumor-pulsed dendritic cell vaccine and activated T cells for cancer patients: rationale, current progress, and perspectives.
Morisaki T; Matsumoto K; Onishi H; Kuroki H; Baba E; Tasaki A; Kubo M; Nakamura M; Inaba S; Yamaguchi K; Tanaka M; Katano M
Hum Cell; 2003 Dec; 16(4):175-82. PubMed ID: 15147037
[TBL] [Abstract][Full Text] [Related]
10. Current status of therapeutic vaccines for non-Hodgkin's lymphoma.
Hurvitz SA; Timmerman JM
Curr Opin Oncol; 2005 Sep; 17(5):432-40. PubMed ID: 16093791
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic lymphoma vaccines: importance of T-cell immunity.
Neelapu SS; Lee ST; Qin H; Cha SC; Woo AF; Kwak LW
Expert Rev Vaccines; 2006 Jun; 5(3):381-94. PubMed ID: 16827622
[TBL] [Abstract][Full Text] [Related]
12. Vaccine therapies for non-Hodgkin's lymphoma.
Timmerman JM
Curr Treat Options Oncol; 2002 Aug; 3(4):307-15. PubMed ID: 12074767
[TBL] [Abstract][Full Text] [Related]
13. The role of active vaccination in cancer immunotherapy: lessons from clinical trials.
Kissick HT; Sanda MG
Curr Opin Immunol; 2015 Aug; 35():15-22. PubMed ID: 26050634
[TBL] [Abstract][Full Text] [Related]
14. T-cell adoptive immunotherapy using tumor-infiltrating T cells and genetically engineered TCR-T cells.
Ikeda H
Int Immunol; 2016 Jul; 28(7):349-53. PubMed ID: 27127191
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy in Hodgkin and non-Hodgkin lymphoma: Innate, adaptive and targeted immunological strategies.
Tun AM; Ansell SM
Cancer Treat Rev; 2020 Aug; 88():102042. PubMed ID: 32521386
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic antitumor efficacy of B cells loaded with tumor-derived autophagasomes vaccine (DRibbles).
Ren H; Zhao S; Li W; Dong H; Zhou M; Cao M; Hu HM; Wang LX
J Immunother; 2014 Oct; 37(8):383-93. PubMed ID: 25198526
[TBL] [Abstract][Full Text] [Related]
17. PD1-CD28 Fusion Protein Enables CD4+ T Cell Help for Adoptive T Cell Therapy in Models of Pancreatic Cancer and Non-hodgkin Lymphoma.
Rataj F; Kraus FBT; Chaloupka M; Grassmann S; Heise C; Cadilha BL; Duewell P; Endres S; Kobold S
Front Immunol; 2018; 9():1955. PubMed ID: 30214445
[No Abstract] [Full Text] [Related]
18. CAR-T Cell Therapy for Lymphoma.
Ramos CA; Heslop HE; Brenner MK
Annu Rev Med; 2016; 67():165-83. PubMed ID: 26332003
[TBL] [Abstract][Full Text] [Related]
19. Vaccine strategies in the treatment of low-grade non-Hodgkin lymphoma.
Koumarianou A; Kountourakis P; Economopoulos T
J Steroid Biochem Mol Biol; 2008 Apr; 109(3-5):230-2. PubMed ID: 18406604
[TBL] [Abstract][Full Text] [Related]
20. Cellular Immunotherapy in B-Cell Malignancy.
Schwarzbich MA; Witzens-Harig M
Oncol Res Treat; 2017; 40(11):674-681. PubMed ID: 29065420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
